PAN-EX supports neoadjuvant chemotherapy in high-risk rectal cancer
Patients with high-risk, locally advanced rectal cancer could benefit from neoadjuvant chemotherapy before undergoing chemoradiotherapy, suggest the results of a pooled analysis.
Source: MedWire News - Category: Consumer Health News Tags: Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers